Pharmacokinetics (PK) and pharmacodynamics (PD) of E7820-an oral sulfonamide with novel, alpha-2 integrin mediated antiangiogenic properties: Results of a phase I study
暂无分享,去创建一个
A. Tolcher | C. Takimoto | M. Mita | A. Mita | E. Rowinsky | Q. Chu | C. Okereke | A. Ricart | E. Rowinsky | P. Desai | M. Goldston